semaglutide and cancer risk Can obesity meds also reduce risk? A retrospective study of 1.1M patients found GLP-1 drugs, especially semaglutide, significantly lower risks for multiple cancers. But not all were equale: liraglutide was linked semaglutide thyroid cancer risk Can

Neuroscience 277:747754 Pekny M, Nilsson M (2005) Astrocyte activation and reactive gliosis

Enhanced pollution and UV stress protection

Ideal candidates typically include: Body composition goals: Individuals focused on reducing body fat percentage while preserving lean muscle mass, those who have reached plateaus with diet and exercise alone, patients seeking metabolically selective approaches without growth hormones broader effects, or individuals interested in targeted fat reduction (particularly abdominal/visceral fat)

"Expanding Medicaid coverage of these drugs could increase access for the almost 40% of adults and 26% of children with obesity in Medicaid," wrote the research team led by senior investigator Clea Bell, a research assistant in state health reform for KFF